MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Validation of Augmented Reality–Based Speech Biomarkers for Objective Detection and Monitoring of Parkinson’s Disease and Atypical Parkinsonian Syndromes

    M. Baran, W. Szecówka, J. Stępień, N. Bozetine, M. Dudek, J. Krzywdziak, M. Zbik, D. Hemmerling, M. Wojcik-Pedziwiatr, M. Rudzińska-Bar (Kraków, Poland)

    Objective: To validate the feasibility and diagnostic potential of an offline, head-mounted augmented reality (AR) system for automated extraction of acoustic and temporal speech biomarkers in…
  • 2026 International Congress

    Acupuncture Combined with Anti-Parkinson Medication Improves Objective Balance Parameters in Patients with Parkinson’s Disease

    X. Liu, Q. Liu, SM. Lin, MY. Yan, YX. Wu, JQ. Fan, YF. Zhang, LX. Zhuang (Guangzhou, China)

    Objective: To evaluate whether acupuncture combined with anti-Parkinson medication improves balance in patients with PD. Background: Parkinson's disease (PD) frequently causes balance dysfunction in older patients.…
  • 2026 International Congress

    Skin Biopsy for Phosphorylated Alpha-Synuclein and DAT Imaging in Patients Diagnosed with Psychogenic Parkinsonism

    J. Phillips, V. Evidente, D. Evidente (Phoenix, USA)

    Objective: Objective:Describe the results of skin biopsy for phosphorylated alpha-synuclein (P-SYN) and dopamine transporter (DAT) imaging in patients previously diagnosed with psychogenic parkinsonism (PP) and…
  • 2026 International Congress

    Adaptive Subthalamic Nucleus Deep Brain Stimulation (aDBS) for Refractory Dyskinesia in Parkinson’s Disease: A Case Report of Two Patients

    C. Lau, V. Tang, A. Chan, L. Au, K. Ma, T. Mok, J. Yeung, L. Cheung, C. Zhu, D. Chan, V. Mok (Hong Kong, Hong Kong)

    Objective: This is a case report of two patients to using adaptive subthalamic nucleus deep brain stimulation (aDBS) for refractory dyskinesia Background: Although continuous subthalamic…
  • 2026 International Congress

    Multimodal Deep Learning for Parkinson’s Disease Screening: Fusing Quantitative Gait Analysis and Clinical Features

    XR. Bai, J. Xu, XY. Liu, HM. Cao (Xi'an, Shaanxi Province, China)

    Objective: To develop and validate a machine learning model integrating quantitative gait parameters and clinical features to enhance the diagnostic accuracy of Parkinson's disease (PD)…
  • 2026 International Congress

    Effects of Modafinil on Motor and Non‑Motor Outcomes in Parkinson’s Disease: A Meta‑Analysis of Randomized, Placebo‑Controlled Trials

    A. Lin, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Cincinnati, USA)

    Objective: To determine the efficacy and safety of modafinil on motor and non-motor outcomes in Parkinson’s disease (PD) using evidence exclusively from randomized placebo‑controlled clinical…
  • 2026 International Congress

    Effects of Botulinum Toxin Therapy on Depression, Anxiety, Pain, and Quality of Life in Patients with Dystonia

    N. Başpınar, Z. Irmak, A. Ersöz, T. Akıncı, G. Yüksel (Istanbul, Turkey)

    Objective: To evaluate changes in depression,anxiety,pain, and quality of life alongside motor improvement in patients with dystonia treated with botulinum toxin(BoNT). Background: Dystonia is a…
  • 2026 International Congress

    Pesticide Exposure and Motor Severity in Parkinson’s Disease in a Mexican Population: A Retrospective Longitudinal Cohort Study

    J. Espinoza-Solares, A. Tapia, L. Cortés, J. López-Moreno, A. Cervantes-Arriaga, M. Rodriguez-Violante (Ciudad de México, Mexico)

    Objective: To evaluate whether pesticide exposure is associated with greater baseline motor severity and accelerated longitudinal motor progression in Mexican patients with Parkinson’s disease (PD).…
  • 2026 International Congress

    Online Assessments Measure Motor and Cognitive Progression in People with and without Parkinson’s Disease

    E. Brown, X. Chen, P. Gonzalez Latapi, D. Weintraub, C. Marras, N. Pavese, L. Chahine, W. Poewe, R. Dobkin, K. Chou, E. Tolosa, A. Noyce, C. Stanley, T. Tropea, L. Racelo, M. Korell, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To evaluate longitudinal progression in online participant reported outcomes (PROs) among people with Parkinson’s disease (PD), prodromal PD, and healthy controls. Background: Collecting PROs…
  • 2026 International Congress

    Gut Microbiome Metagenomics in Parkinson’s Disease Stratified by the Asian-Prevalent LRRK2 Variants p.G2385R and p.R1628P

    TS. Toh, JW. Hor, CH. Lin, J. Tee, Z. Pan, AK. Ng, V. Balakrishnan, AN. Khairul Anuar, LC. Lit, CW. Chong, SY. Lim, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To compare gut microbiome profiles of manifesting LRRK2 p.G2385R or p.R1628P carriers (LRRK2-PD) and idiopathic Parkinson’s disease patients (iPD). Background: Leucine-rich repeat kinase 2…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley